BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29475547)

  • 1. A rare presentation of a posttransplant lymphoproliferative disorder.
    Sivayoganathan S; Ariyawansa D; Ambawatte P; Galahitiyawa C; Herath C
    Kidney Int; 2018 Mar; 93(3):761. PubMed ID: 29475547
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant Lymphoproliferative Disease and Inhibitors of Mammalian Target of Rapamycin: When a Quick Look Back Can Change the Perspective.
    Castillo-Eraso L; Melilli E; Cabre C; Manonelles A; Landeyro J; Bestard O; Cruzado JM; Martinez-Vea A
    Exp Clin Transplant; 2018 Dec; 16(6):761-764. PubMed ID: 28666406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
    Dierickx D; Cardinaels N
    World J Gastroenterol; 2015 Oct; 21(39):11034-43. PubMed ID: 26494960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Ulcerative Nodular Lesions.
    Abe K; Okamura T; Isono A
    Gastroenterology; 2016 Apr; 150(4):827-8. PubMed ID: 26930016
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation.
    Hayase E; Fujimoto K; Mitsuhashi T; Hatanaka Y; Yoshida M; Takemura R; Iwasaki J; Shiratori S; Sugita J; Kondo T; Tanaka J; Imamura M; Matsuno Y; Teshima T
    Transplantation; 2014 Jan; 97(1):e1-3. PubMed ID: 24374766
    [No Abstract]   [Full Text] [Related]  

  • 7. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM; Krams SM
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Kaposi sarcoma and hemophagocytic lymphohistiocytosis associated with human herpesvirus 8 in a renal transplant recipient.
    Park YJ; Bae HJ; Chang JY; Yang CW; Chung BH
    Korean J Intern Med; 2017 Jul; 32(4):750-752. PubMed ID: 26842102
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoproliferative Disease After Pediatric Liver Transplant.
    Özçay F
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):79-81. PubMed ID: 28302005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA; Meier JD; Stallworth CR; White DR
    Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Persistent Positive EBV Viral Load and Risk of Solid Cancer in Kidney Transplant Patients.
    Bamoulid J; Courivaud C; Coaquette A; Crépin T; Carron C; Gaiffe E; Roubiou C; Rebibou JM; Ducloux D
    Transplantation; 2017 Jun; 101(6):1473-1478. PubMed ID: 27367471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
    Ninan MJ; Datta YH
    Am J Hematol; 2010 Aug; 85(8):635-7. PubMed ID: 20578201
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
    Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature.
    Shimizu S; Inokuma D; Murata J; Kikuchi K; Ito T; Fukasawa Y; Mukai M; Moriuchi R
    Acta Derm Venereol; 2015 Mar; 95(3):366-7. PubMed ID: 25138609
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr Virus-Associated Nodal Marginal Zone Lymphoma: Part of the Spectrum of Posttransplant Lymphoproliferative Disorder?
    Cheung CY; Lau WH; Cheuk W
    Int J Surg Pathol; 2019 Feb; 27(1):94-97. PubMed ID: 29944019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient.
    Chandra A; Kaul A; Aggarwal V; Srivastava D
    Saudi J Kidney Dis Transpl; 2017; 28(4):942-944. PubMed ID: 28748904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Secretion of TNF-α by Monocytes Stimulated With EBV Peptides Associates With Infectious Complications After Kidney Transplantation.
    Vallin P; Désy O; Béland S; Bouchard-Boivin F; Houde I; De Serres SA
    Transplantation; 2018 Jun; 102(6):1005-1013. PubMed ID: 29470349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus-Positive Mucocutaneous Ulcer in a Pediatric Patient-Case Report.
    Coelho KMPA; Bublitz GS; Condeixa de França PH; Stall J; Hanauer AD; Sangueza JM
    Am J Dermatopathol; 2020 Apr; 42(4):e49-e52. PubMed ID: 31764088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.